Mounjaro®
Starting from £179.99/mo
Start journey Learn moreMounjaro (tirzepatide) causes side effects in most people who take it, and the majority are digestive: nausea, loose stools, constipation, and stomach discomfort are the most commonly reported. Understanding which bad effects are normal, which settle quickly, and which need medical attention is the most useful thing you can read before or during treatment. Mounjaro is a prescription-only medicine; a clinician assesses whether it is appropriate for you before any prescription is issued.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
The most frequently reported bad effects of Mounjaro are all digestive, and they cluster around two moments: when you first start treatment on 2.5mg, and each time the dose steps up. Nausea is the one people notice most. It usually arrives within the first day or two after an injection and softens (often considerably) within a week. Vomiting, diarrhoea, constipation, indigestion, reflux and burping follow a similar pattern.
There is a common belief that these side effects mean the medicine is damaging you, or that they will last throughout treatment. For most people that is not what happens. The digestive system is adjusting to a medicine that slows how quickly food leaves the stomach; once it adjusts, the discomfort usually recedes. Small, lower-fat meals, eating slowly and staying well hydrated all help the adjustment along.
Beyond the gut, Mounjaro can also cause fatigue, headache, and dizziness, particularly early on. Injection-site reactions (redness, itching or a small lump at the injection point) are reported in some users and generally resolve without treatment. The NHS patient information page for tirzepatide lists these effects in full and is worth reading before your first pen.
For a broader look at how tirzepatide behaves in the body as doses progress, the effects of tirzepatide at each stage page covers this in detail.
Most side effects are unpleasant but not dangerous. A smaller number require prompt action, and one in particular was important enough that the MHRA issued a dedicated safety communication about it.
In January 2026, the MHRA's Drug Safety Update for GLP-1 medicines highlighted acute pancreatitis as an infrequent but potentially serious effect. The warning signs are severe stomach pain that is persistent and may spread towards the back, with or without vomiting. If you experience this, stop eating and drinking and seek urgent medical help. Do not wait to see if it passes.
Other effects that need prompt attention include: signs of an allergic reaction (swollen face or throat, difficulty breathing, rapid heartbeat); severe or prolonged vomiting and diarrhoea leading to dehydration; gallbladder symptoms (sharp upper-right abdominal pain, particularly after eating); and, for people with diabetes, symptoms of very low blood sugar. Low mood or thoughts of self-harm have also been reported with GLP-1 medicines and should be taken seriously, tell your GP or prescriber straight away.
If you want to compare how the side-effect profile looks across the full Mounjaro dose range, the page on how Mounjaro affects the body walks through each mechanism.
A few Mounjaro effects don't make the headline lists but come up regularly in practice. Muscle weakness and a reduction in lean muscle mass can occur alongside fat loss, particularly if protein intake drops and physical activity stops. This isn't inevitable, but it is worth addressing from the start: adequate protein, consistent strength work and regular clinical review all matter. Our page on Mounjaro and muscle weakness goes into the detail.
Women using oral contraceptives should add a non-oral method (condoms, for instance) for the first four weeks of treatment and for four weeks after every dose increase. Mounjaro slows gastric emptying, which can reduce how well the pill is absorbed; semaglutide does not carry the same documented concern. This is one practical detail that is easy to miss and matters from day one. Pregnancy, breastfeeding and trying to conceive are all situations where Mounjaro is not recommended; the same applies to anyone under 18.
Hair thinning is sometimes attributed to Mounjaro but is more likely a response to rapid weight loss itself (a known phenomenon called telogen effluvium) rather than a direct drug effect. It is usually temporary.
The longer-term effects of Mounjaro page covers what people notice after several months on treatment, including how appetite and energy levels tend to change over time. And if you are already on treatment and want to check whether a specific symptom fits the pattern, the full side effects guide is the right place to look.
Good clinical oversight doesn't stop at the prescription. Every repeat order at nume goes through a fresh clinical review, a real prescriber reads your case again, not software. That review is the moment to flag anything that has changed: a symptom that hasn't settled, a new medicine started since the last pen, or a health change your original consultation didn't cover.
You can also report suspected side effects directly through the MHRA's Yellow Card scheme, it is open to patients and carers and is one of the main ways regulators spot patterns in real-world use. This matters particularly for a medicine like Mounjaro that carries a Black Triangle (▼) status, meaning additional MHRA monitoring is ongoing.
If you have read through the side-effect picture and want to understand the broader context of what Mounjaro does (including the trial results and how it compares with other licensed medicines) the Mounjaro overview page brings it all together. Questions about cost are answered on our Mounjaro pricing page, including what a legitimate private prescription should include.
If you would like a clinician to review whether Mounjaro is right for your circumstances, you can start your free consultation with our prescribers today.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.